B. A. VAN TINE ET AL: "ER and PI3K Independently Modulate Endocrine Resistance in ER-Positive Breast Cancer", CANCER DISCOVERY, vol. 1, no. 4, 1 September 2011 (2011-09-01), pages 287-288, XP055145623, ISSN: 2159-8274, DOI: 10.1158/2159-8290.CD-11-0192 (B1)

Dennis J. Slamon: "2013 Breast Cancer Highlight - Palbociclib (PD-0332991), a "Breakthrough Therapy" for Breast Cancer, Breast Cancer Research Program, Congressionally Directed Medical Research Programs", , 15 May 2013 (2013-05-15), pages 1-2, XP055158107, Retrieved from the Internet: URL:http://cdmrp.army.mil/bcrp/research_hi ghlights/13slamon_highlight.shtml [retrieved on 2014-12-11] (B1)

FINN RICHARD S ET AL: "PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro", BREAST CANCER RESEARCH, CURRENT SCIENCE, LONDON, GB, vol. 11, no. 5, 29 October 2009 (2009-10-29), page R77, XP021065288, ISSN: 1465-5411, DOI: 10.1186/BCR2419 (B1)

JOSÉ BASELGA ET AL: "Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, US, vol. 366, no. 6, 9 February 2012 (2012-02-09), pages 520-529, XP002684647, ISSN: 0028-4793, DOI: 10.1056/NEJMOALL09653 [retrieved on 2011-12-07] (B1)

WO-A1-2013/006532 (B1)

TODD W MILLER ET AL: "ER[alpha]-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer", CANCER DISCOVERY, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 1, no. 4, 1 September 2011 (2011-09-01), pages 338-351, XP002683182, ISSN: 2159-8274, DOI: 10.1158/2159-8290.CD-11-0101 [retrieved on 2011-07-20] (B1)

VORA SADHNA R ET AL: "CDK 4/6 Inhibitors SensitizePIK3CAMutant Breast Cancer to PI3K Inhibitors", CANCER CELL, vol. 26, no. 1, 14 July 2014 (2014-07-14), pages 136-149, XP028880794, ISSN: 1535-6108, DOI: 10.1016/J.CCR.2014.05.020 (B1)

WO-A1-2011/101409 (B1)

Robert L Sutherland ET AL: "CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+ disease", Breast cancer research : BCR, 1 January 2009 (2009-01-01), pages 112-112, XP055145540, England DOI: 10.1186/bcr2454 Retrieved from the Internet: URL:http://www.pubmedcentral.nih.gov/artic lerender.fcgi?artid=2815549&tool=pmcentrez &rendertype=abstract [retrieved on 2014-10-10] (B1)